Nomura Holdings Inc Kamada LTD Transaction History

Nomura Holdings Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	SELL	$5.43 - $6.81 $127,605 - $160,035	-23,500 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.21 - $6.82 $522,302 - $683,705	-100,250 Reduced 81.01%	23,500 $155,000
Q3 2021 Nov 15, 2021	BUY	$5.25 - $5.87 $257,250 - $287,630	49,000 Added 65.55%	123,750 $653,000
Q2 2021 Aug 16, 2021	BUY	$5.67 - $6.33 $423,832 - $473,167	74,750 New	74,750 $435,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.